Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Forensic Science International|March 2, 2016
Is toxicity of PMMA (paramethoxymethamphetamine) associated with cytochrome P450 pharmacogenetics?Merete Vevelstad, Elisabeth Leere Øiestad, Sara Bremer, et al.
European Journal of Clinical Pharmacology|March 25, 2014
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipientsIngrid Lunde, Sara Bremer, Karsten Midtvedt, et al.
Therapeutic Drug Monitoring|July 28, 2017
Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective StudyRagnhild Heier Skauby, Anna Bjerre, Ingjerd Sæves, et al.
British Journal of Clinical Pharmacology|July 8, 2017
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantationSara Bremer, Nils T Vethe, Morten Skauby, et al.
Transplantation|August 23, 2014
Use of generic tacrolimus in elderly renal transplant recipients: precaution is neededIda Robertsen, Anders Åsberg, Aleksander Olsen Ingerø, et al.
The International Journal of Pharmacy Practice|December 31, 2019
Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmaciesRagnar Hovland, Sara Bremer, Christine Frigaard, et al.
Transplantation|November 27, 2008
Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipientsPål Falck, Anders Asberg, Karen-Therese Byberg, et al.
Transplantation|January 15, 2008
Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppressionSara Bremer, Randeep Mandla, Nils T Vethe, et al.
Journal of Translational Medicine|July 29, 2009
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot studySara Bremer, Nils T Vethe, Helge Rootwelt, et al.
Therapeutic Drug Monitoring|October 2, 2013
Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantationIngjerd Sæves, Pål-Dag Line, Sara Bremer, et al.
Pageof 3